2025 Annual Meeting | S29 - Neuro-oncology
Program Materials Program Evaluations
Sigmund H. Hsu, MD | No disclosure on file |
Scott R. Plotkin, MD, PhD, FAAN | Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care. |
Kaleb H. Yohay, MD | Dr. Yohay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Yohay has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Yohay has received publishing royalties from a publication relating to health care. |
Phioanh L. Nghiemphu, MD, FAAN | Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Simpson Healthcare. Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springswork. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Nghiemphu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Springworks. The institution of Dr. Nghiemphu has received research support from Erasca. The institution of Dr. Nghiemphu has received research support from Springswork. The institution of Dr. Nghiemphu has received research support from Children's Tumor Foundation. The institution of Dr. Nghiemphu has received research support from NIH-NCI . The institution of Dr. Nghiemphu has received research support from DOD. The institution of Dr. Nghiemphu has received research support from GCAR. |
Jay-Jiguang Zhu, MD, PhD, FAAN | The institution of Dr. Zhu has received research support from Novocure, Inc. The institution of Dr. Zhu has received research support from Five Prime pharmaceutical. The institution of Dr. Zhu has received research support from Denovo, inc. The institution of Dr. Zhu has received research support from Boston Biomedical Sumitomo Dainippon Pharma Global Oncology. The institution of Dr. Zhu has received research support from CNS pharmaceutical. The institution of Dr. Zhu has received research support from ABM Therapeutics Corporation . The institution of Dr. Zhu has received research support from Chimerix Inc. |
Nicole Ullrich, MD, PhD, MMSci, FAAN | Dr. Ullrich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care. |
Nimish A. Mohile, MD, FAAN | The institution of Dr. Mohile has received research support from Novocure. |
Timothy R. Gershon, MD, PhD | No disclosure on file |
Jeremy Rudnick, MD | Dr. Rudnick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure. |
Katherine B. Peters, MD, PhD, FAAN | Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals. The institution of Dr. Peters has received research support from Nuvation. |
Brett J. Theeler, MD, FAAN | Dr. Theeler has nothing to disclose. |
Jorg Dietrich, MD, PhD, FAAN | Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care. |
Jethro Hu, MD | Dr. Hu has nothing to disclose. |
Maria Martinez-Lage, MD | The institution of Dr. Martinez-Lage has received research support from NIH. |
Sabine Mueller, MD | The institution of Dr. Mueller has received research support from BMS, Regeneron, Novartis, Chimerix, Kazia, Blueprint, Sonalasence, DayOne, Pfizer, Gilead. |
Sebastien Perreault, MD | Dr. Perreault has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Perreault has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Perreault has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer. The institution of Dr. Perreault has received research support from Novartis. The institution of Dr. Perreault has received research support from Rocher. |
Justin T. Jordan, MD, MPH, FAAN | Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Recursion Pharmaceuticals, Inc. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akeila Bio. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has stock in Navio Theragnostics. Dr. Jordan has stock in The Doctor Lounge. An immediate family member of Dr. Jordan has stock in OldGate. Dr. Jordan has stock in Akeila Bio. Dr. Jordan has stock in Shepherd Therapeutics. Dr. Jordan has stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has a non-compensated relationship as a board member with United Council for Neurologic Subspecialties that is relevant to AAN interests or activities. |
Nicholas Blondin, MD | Dr. Blondin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure, Inc.. Dr. Blondin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure, Inc.. |
Adrienne Boire, MD, PhD, FAAN | Dr. Boire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apelis Pharmaceuticals. The institution of Dr. Boire has received research support from National Cancer Institute. The institution of Dr. Boire has received research support from Center for Experimental Therapeutics. The institution of Dr. Boire has received research support from STARR Cancer Consortium. The institution of Dr. Boire has received research support from National Cancer Institute. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. |
Rebecca Naor | Rebecca Naor has nothing to disclose. |
Alissa A. Thomas, MD, FAAN | The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals. |
Wolfgang Wick | The institution of Wolfgang Wick has received research support from Roche. The institution of Wolfgang Wick has received research support from Pfizer. The institution of Wolfgang Wick has received research support from Apogenix. |
Lauren Schaff, MD, FAAN | Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO. Dr. Schaff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BTG Pharmaceuticals. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. The institution of Dr. Schaff has received research support from BTG, plc. The institution of Dr. Schaff has received research support from Merck. The institution of Dr. Schaff has received research support from DebioPharm. |
Mary Jane Lim-Fat, MD, FRCPC | Dr. Lim Fat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Lim Fat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Lim Fat has received research support from Brain Cancer Canada. |
Hans H. Shuhaiber, MD | The institution of Dr. Shuhaiber has received research support from SPRINGWORKS . The institution of Dr. Shuhaiber has received research support from RECURSION . The institution of Dr. Shuhaiber has received research support from AstraZeneca. The institution of Dr. Shuhaiber has received research support from CTF. The institution of Dr. Shuhaiber has received research support from NFLECTION . |
Rajiv Magge, MD | Dr. Magge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG Clinical. Dr. Magge has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Medplace. Dr. Magge has received personal compensation in the range of $5,000-$9,999 for serving as a Founding Medical Content Contributor with Roon. |
Akanksha Sharma, MD | Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Generation Care Hospice. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curio Science. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDPI. Dr. Sharma has stock in Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Incyte. The institution of Dr. Sharma has received research support from Novocure. The institution of Dr. Sharma has received research support from Apollomics. The institution of Dr. Sharma has received research support from Curis. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities. |
Vanessa Merker | The institution of Vanessa Merker has received research support from Children's Tumor Foundation . The institution of Vanessa Merker has received research support from NF Northeast. The institution of Vanessa Merker has received research support from Patient Centered Outcomes Research Institute. The institution of Vanessa Merker has received research support from U.S. Department of Defense . The institution of Vanessa Merker has received research support from Neurofibromatosis Therapeutic Accleration Project. Vanessa Merker has received personal compensation in the range of $10,000-$49,999 for serving as a Science Writer with Neurofibromatosis Network. |
Jessica M. Besbris, MD | Dr. Besbris has nothing to disclose. |
Maya Hrachova, DO | Dr. Hrachova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Therapeutics. |
David Viskochil, MD, PhD | The institution of David Viskochil, MD, PhD has received research support from Astellas. The institution of David Viskochil, MD, PhD has received research support from Takeda. The institution of David Viskochil, MD, PhD has received research support from Springworks. The institution of David Viskochil, MD, PhD has received research support from NFlection. |
Lauryn Hemminger | Dr. Hemminger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. |
Leon D. Kaulen, MD | Dr. Kaulen has nothing to disclose. |
Philipp Karschnia | Philipp Karschnia has nothing to disclose. |
Christy Soares, MD | Dr. Soares has nothing to disclose. |
Huda Alalami, MD | Dr. Alalami has nothing to disclose. |
Nicholas S. Haberli, MD | Dr. Haberli has nothing to disclose. |
Adam Uppendahl, MD | Dr. Uppendahl has nothing to disclose. |
Pouneh Amir Yazdani, MD | Dr. Amir Yazdani has nothing to disclose. |
Emily Downing-Mahli, NP | Mrs. Downing-Mahli has nothing to disclose. |
Nitin Tandon | Nitin Tandon has stock in BrainDynamics. The institution of Nitin Tandon has received research support from NIH. |
Jeremy Abramson | No disclosure on file |
Matthew Frigault | No disclosure on file |
Kevin Bielamowicz | Kevin Bielamowicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Kevin Bielamowicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Kevin Bielamowicz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. |
Ganesh Shankar | Ganesh Shankar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Depuy. The institution of Ganesh Shankar has received research support from NuVasive. |
Heather B. Radtke, MS | Ms. Radtke has received personal compensation for serving as an employee of Children's Tumor Foundation. |
Adam Resnick, PhD | Dr. Resnick has nothing to disclose. |
Jordan Hansford, MBBS | Prof. Hansford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Prof. Hansford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Prof. Hansford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. |
David Ziegler, MBBS, PhD, FRACP | Prof. Ziegler has received personal compensation in the range of $0-$499 for serving as a Consultant for Medison Pharma. Prof. Ziegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Ziegler has received personal compensation in the range of $0-$499 for serving as an Expert Witness for The Law Office of Conrad Curry. Prof. Ziegler has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Lex Medicus. |
Birgit Geoerger, MD, PhD | Dr. Geoerger has nothing to disclose. |
Daniel Orbach, MD | Dr. Orbach has nothing to disclose. |
Matthew T. Clarke, MD, PhD | Dr. Clarke has nothing to disclose. |
Alvaro Lassaletta Atienza, MD, PhD | Dr. LASSALETTA ATIENZA has nothing to disclose. |
Craig Erker, MD | Dr. Erker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. |
Theodore W. Laetsch, MD | Dr. Laetsch has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Advanced Microbubbles. Dr. Laetsch has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AI Therapeutics. Dr. Laetsch has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Laetsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ITM Oncologics. Dr. Laetsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Laetsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Laetsch has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO. The institution of Dr. Laetsch has received research support from Pfizer. The institution of Dr. Laetsch has received research support from Bayer. The institution of Dr. Laetsch has received research support from Lilly. The institution of Dr. Laetsch has received research support from US Department of Defense. The institution of Dr. Laetsch has received research support from National Cancer Institute. The institution of Dr. Laetsch has received research support from Stand Up to Cancer. The institution of Dr. Laetsch has received research support from Alex Lemonade Stand Foundation. |
Mélanie Alves, MSc | Mrs. Alves has nothing to disclose. |
Holly B. Lindsay, MD | Dr. Lindsay has nothing to disclose. |
Lindsey Hoffman, DO | Dr. Hoffman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Children's Oncology Group. Dr. Hoffman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Pediatric Brain Tumor Consoritum. Dr. Hoffman has received personal compensation in the range of $500-$4,999 for serving as a Advisory board member with Day One Biopharmaceuticals. |
Scott I. Raskin, DO | Dr. Raskin has nothing to disclose. |
Alexander Drilon, MD | Dr. Drilon has received personal compensation for serving as an employee of 14ner/Elevation Oncology, Amgen, Anheart Therapeutics, Abbvie, ArcherDX, AstraZeneca, Bayer, Beigene, BergenBio, Blueprint Medicines, Boundless Bio, BMS, Chugai Pharmaceutical, EcoR1, EMD Serono, Entos, Exelixis, Helsinn, Hengrui Therapeutics, Ignyta/Genentech/Roche, Innocare, Janssen, Loxo/Lilly, Merus, Monopteros, MonteRosa, Novartis, Nuvalent, Pfizer, Prelude, Regeneron, Repare RX, Takeda/Ariad/Millenium, Treeline Bio, TP Therapeutics, Tyra Biosciences, Verastem, Zymeworks. Dr. Drilon has received personal compensation for serving as an employee of Answers in CME, Applied Pharmaceutical Science, Inc, AXIS, Clinical Care Options, Doc Congress, EPG Health, Harborside Nexus, I3 Health, Imedex, Liberum, Medendi, Medscape, Med Learning, MedTalks, MJH Life Sciences, MORE Health, Ology, OncLive, Paradigm, Peerview Institute, PeerVoice, Physicians 好色先生 Resources, Projects in Knowledge, Resources, Remedica Ltd , Research to Practice, RV More, Springer Healthcare, Targeted Oncology, TouchIME, WebMD. Dr. Drilon has stock in mBrace, Treeline. Dr. Drilon has received publishing royalties from a publication relating to health care. Dr. Drilon has a non-compensated relationship as a PI of Industry Trial (Associated Research to Institution) with Foundation Medicine, Teva, Taiho, GlaxSmithKlein, PharmaMar that is relevant to AAN interests or activities. |
Michael Fisher, MD | Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks. The institution of Dr. Fisher has received research support from AstraZeneca/Alexion. The institution of Dr. Fisher has received research support from Array BioPharma. |
François Doz, MD | Prof. DOZ has received publishing royalties from a publication relating to health care. |
Lauriane Lemelle, MD | Dr. Lemelle has received research support from Fondation nuovo Soldati. Dr. Lemelle has received research support from Fondation Servier. |
Christina Coleman, DO | Dr. COLEMAN has nothing to disclose. |
Nada Jabado, MD, PhD | Prof. jabado has nothing to disclose. |
Nick Gottardo, PhD, FRACP, MBChB | Prof. Gottardo has received research support from Perth Children's Hospital Foundation Stan Perron Charitable Foundation Chair in Paediatric Oncology & Haematology. |
Dusica babovic-vuksanovic, MD | Dr. babovic-vuksanovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca/Alexion. Dr. babovic-vuksanovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks. Dr. babovic-vuksanovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. babovic-vuksanovic has received research support from SprinWorks. Dr. babovic-vuksanovic has received publishing royalties from a publication relating to health care. Dr. babovic-vuksanovic has received personal compensation in the range of $500-$4,999 for serving as a USMLE items review with NBME. |
Elke Pfaff, MD | Dr. Pfaff has nothing to disclose. |
Yoshua Esquenazi, MD | Dr. Esquenazi has nothing to disclose. |
Jan Kemnade, MD, PhD | Dr. Kemnade has nothing to disclose. |
Corey Mossop, MD | Dr. Mossop has nothing to disclose. |
Christina Clay, MD | Dr. Clay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for law firm. Dr. Clay has stock in investment portfolio. |
Laura Aguilar, MD, PhD | Dr. Aguilar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Diakonos Oncology. An immediate family member of Dr. Aguilar has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Candel Therapeutics. Dr. Aguilar has stock in Candel Therapeutics . |
Eva H. Schumann | Ms. Schumann has received personal compensation for serving as an employee of Diakonos Oncology. |
Mia Vu, CRC | Miss Vu has nothing to disclose. |
Keenan Ernste | Mr. Ernste has received intellectual property interests from a discovery or technology relating to health care. |
Akshar J. Trivedi, MS | Mr. Trivedi has nothing to disclose. |
Madhuri S. Namekar, MSc MS | Mrs. Namekar has nothing to disclose. |
Vanaja konduri, PhD | Dr. konduri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Diakonos Oncology. Dr. konduri has stock in Diakonos Oncology. The institution of Dr. konduri has received research support from Diakonos Oncology. |
Rodrick C. Zvavanjanja, MD | Dr. Zvavanjanja has nothing to disclose. |
Wei Liu, MD | Ms. Liu has nothing to disclose. |
William K. Decker, PhD | Dr. Decker has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Diakonos Oncology Corp.. Dr. Decker has stock in Diakonos Research, Ltd.. The institution of Dr. Decker has received research support from NIH. The institution of Dr. Decker has received research support from ALSF. The institution of Dr. Decker has received research support from Cancer Cures 4 Kids. Dr. Decker has received intellectual property interests from a discovery or technology relating to health care. |
LJ Amaral, MS, RD | Ms. Amaral has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Formularies . |
Elissa K. Rosenberg | Ms. Rosenberg has nothing to disclose. |
Almar Guevarra, RN | Mr. Guevarra has nothing to disclose. |
Samira Kadri, NP | Mrs. Kadri has nothing to disclose. |
Philip Chang, DO | Dr. Chang has nothing to disclose. |
Alan Turtz, MD | Dr. Turtz has received intellectual property interests from a discovery or technology relating to health care. |
Sabina Amin, MD | Dr. Amin has nothing to disclose. |
joanna wilson, RN | Ms. wilson has nothing to disclose. |
Carrie Kohler, Chaplain | Ms. Kohler has nothing to disclose. |
Alisha Cabrera, RN | Miss Cabrera has nothing to disclose. |
Tomas M. Wagmister, LCSW | Mr. Wagmister has nothing to disclose. |
Lauren Weintraub, MD | Dr. Weintraub has nothing to disclose. |
Michael D. Weber, PharmD | Dr. Weber has received personal compensation for serving as an employee of SpringWorks Therapeutics. Dr. Weber has stock in SpringWorks Therapeutics. |
L Mary M. Smith, PhD | Dr. Smith has received personal compensation for serving as an employee of SpringWorks Therapeutics Inc. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SpringWorks Therapeutics. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Lifordi Immunotherapeutics. |
Alpa o. Sidhu, MBBS, PhD | The institution of Dr. Sidhu has received research support from SpringWorks Therapeutics. |
Christopher L. Moertel, MD | Dr. Moertel has received personal compensation for serving as an employee of OX2 Therapeutics. Dr. Moertel has received personal compensation for serving as an employee of Alexion . Dr. Moertel has received personal compensation for serving as an employee of Springworks. Dr. Moertel has stock in OX2 Therapeutics. Dr. Moertel has received intellectual property interests from a discovery or technology relating to health care. |
FOUAD M. HAJJAR, MD | Dr. HAJJAR has nothing to disclose. |
Rene Y. McNall-Knapp, MD | The institution of Dr. McNall-Knapp has received research support from SpringWorks. The institution of Dr. McNall-Knapp has received research support from Alexion. The institution of Dr. McNall-Knapp has received research support from Pfizer. |
Armend Lokku, PhD | Dr. Lokku has nothing to disclose. |
Angela Hirbe, MD, PhD | Dr. Hirbe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks Therapeutic. Dr. Hirbe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Hirbe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aadi Subsidiary Inc. The institution of Dr. Hirbe has received research support from Tango. Dr. Hirbe has received intellectual property interests from a discovery or technology relating to health care. |
Uri Tabori, MD | Dr. Tabori has nothing to disclose. |
Joseph Georges, DO, PhD | Dr. Georges has received intellectual property interests from a discovery or technology relating to health care. |
Michal Zapotocky, MD, PhD | Dr. Zapotocky has nothing to disclose. |
Nathan J. Robison, MD | The institution of Dr. Robison has received research support from Pfizer. |
Stefan Pfister, MD | Prof. Pfister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioskryb. Prof. Pfister has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for PMC. Prof. Pfister has received intellectual property interests from a discovery or technology relating to health care. |
Audrey-Anne Lamoureux, MD | Dr. Lamoureux has nothing to disclose. |
Madison Stern, RD | Miss Stern has nothing to disclose. |
Elaine Wittert, LCSW | Ms. Wittert has nothing to disclose. |
Scott A. Irwin, MD, PhD | Dr. Irwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Prosoma. Dr. Irwin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Renewed Mental Health Group. Dr. Irwin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UptoDate. The institution of Dr. Irwin has received research support from NCI. Dr. Irwin has received publishing royalties from a publication relating to health care. |
Nicholas K. Foreman, MD | Prof. Foreman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Georgia University. |
Andrea Cocjin | No disclosure on file |
Sofia Doubrovinskaia | No disclosure on file |
Colby James Hofferek | No disclosure on file |
Sashana Macatangay | No disclosure on file |
Rosario Pulido | No disclosure on file |
Vinod Ravi | No disclosure on file |
Karina Suarez Perez | No disclosure on file |
Desiree Williams-Trinidad | No disclosure on file |